Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sympathetic Pathways: Sympathetic Chain Ganglia01:20

Sympathetic Pathways: Sympathetic Chain Ganglia

The sympathetic chain ganglia, also known as the sympathetic trunk ganglia or paravertebral ganglia, are a series of ganglia located bilaterally on either side of the spinal column. These ganglia serve as relay stations for the sympathetic nervous system. Preganglionic neurons originating in the spinal cord project their axons to the sympathetic chain ganglia. Within the ganglia, these preganglionic fibers synapse with postganglionic neurons.The postganglionic neurons of the sympathetic trunk...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tissue-Adaptive, Adhesive, and Ultra-Conformal Polymer Nanomesh-Based Implantable Bioelectrode for Long-Term Stable Electrical Stimulation.

Advanced healthcare materials·2026
Same author

Therapeutic Potential of Bovine Amniotic Membrane in Wound Healing: Insights from a Mouse Model.

Cells·2025
Same author

Effectiveness of a Facet Joint Block Versus a Medial Branch Block in Spinal Pain Management: A Systematic Review and Meta-Analysis.

Neurospine·2025
Same author

Intraoperative Facet Joint Block Reduces Pain After Oblique Lumbar Interbody Fusion: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial.

The Journal of bone and joint surgery. American volume·2025
Same author

Intraoperative Facet Joint Block Reduces Pain After Oblique Lumbar Interbody Fusion: A Double-Blinded, Randomized, Placebo-Controlled Clinical Trial.

The Journal of bone and joint surgery. American volume·2025
Same author

Understanding the Measurement of Pressure Within the Spinal Cord to Optimize Spinal Cord Perfusion Pressure Using a Porcine Model of Spinal Cord Injury.

Journal of neurotrauma·2025

Related Experiment Video

Updated: Jun 27, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Primary paraspinal malignant peripheral nerve sheath tumor.

Kyoung-Tae Kim1, Yong-Suk Park, Jeong-Taik Kwon

  • 1Department of Neurosurgery, College of Medicine, Chung-Ang University, Seoul, Korea.

Journal of Korean Neurosurgical Society
|December 20, 2008
PubMed
Summary

Malignant peripheral nerve sheath tumors (MPNSTs) are rare. This case report details a cervical MPNST in a patient without neurofibromatosis, highlighting a unique presentation and surgical approach.

Keywords:
Cervical paraspinal spaceMalignant peripheral nerve sheath tumorOccipital triangle

More Related Videos

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
07:10

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Published on: March 7, 2011

Related Experiment Videos

Last Updated: Jun 27, 2026

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
08:57

Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models

Published on: May 17, 2024

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents
07:10

Orthotopic Xenografting of Human Luciferase-Tagged Malignant Peripheral Nerve Sheath Tumor Cells for in vivo Testing of Candidate Therapeutic Agents

Published on: March 7, 2011

Area of Science:

  • Oncology
  • Neurosurgery
  • Pathology

Background:

  • Malignant peripheral nerve sheath tumors (MPNSTs) are rare and aggressive neoplasms arising from peripheral nerves.
  • While often associated with neurofibromatosis type 1 (NF1), MPNSTs can occur sporadically.
  • Cervical MPNSTs are particularly uncommon, presenting diagnostic and therapeutic challenges.

Observation:

  • A case of a primary cervical MPNST is presented in a patient without a history of neurofibromatosis.
  • The tumor was identified in the left C6-7 foramen, causing compression of the C7 nerve root.
  • Surgical resection was successfully performed via an occipital triangle approach.

Findings:

  • The study details a rare instance of a sporadic cervical MPNST.
  • The anatomical location and nerve root compression are described.
  • Successful surgical management through a specific surgical corridor is documented.

Implications:

  • This case expands the understanding of rare tumor presentations in the cervical spine.
  • It underscores the importance of considering sporadic MPNSTs in the differential diagnosis of neck masses.
  • The successful surgical approach may offer insights for managing similar rare tumors.